Balyasny Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-225,000
| Closed | -$3.95M | – | 2475 |
|
2021
Q3 | $3.95M | Buy |
+225,000
| New | +$3.95M | 0.02% | 745 |
|
2020
Q4 | – | Sell |
-234,122
| Closed | -$3.33M | – | 1602 |
|
2020
Q3 | $3.33M | Buy |
+234,122
| New | +$3.33M | 0.02% | 563 |
|
2020
Q2 | – | Sell |
-326,065
| Closed | -$1.32M | – | 1443 |
|
2020
Q1 | $1.32M | Buy |
+326,065
| New | +$1.32M | 0.02% | 586 |
|